ArticleMedical & biological engineering & computing2026
A computationally efficient biomedical text processing framework for pharmacovigilance: integrating low-rank adaptation and interpretable AI for adverse drug reaction detection.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of adverse drug reactions (ADRs) is crucial for patient safety but remains challenging due to underreporting and delayed data in traditional pharmacovigilance. This study proposes a computationally efficient and interpretable framework for ADR detection by integrating Low-Rank Adaptation (LoRA) and SHapley Additive Explanations (SHAP) with encoder-based transformer models (BERT, DistilBERT, RoBERTa). Leveraging over 3,900 annotated tweets, our approach demonstrates that LoRA reduces trainable parameters and training costs by up to 50%, while preserving high classification accuracy (above 98%) across three disease classes. SHAP analysis provides actionable interpretability, revealing that the models consistently rely on clinically relevant terms, such as drug names and symptoms, to drive predictions. Compared to traditional finetuning, LoRA and Efficient Finetuning of Quantized LLMs (QLoRA) offer a robust and scalable alternative for processing noisy, informal social media data, making real-time ADR monitoring feasible in resource-constrained healthcare settings. This framework strikes a balance between computational efficiency, interpretability, and predictive performance, supporting the integration of pharmacovigilance into clinical decision support systems for safer patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.